- Home
- YCBD vs TTNP Comparison
YCBD vs TTNP Comparison
Compare YCBD & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YCBD
- TTNP
- Stock Information
- Founded
- YCBD 2015
- TTNP 1991
- Country
- YCBD United States
- TTNP United States
- Employees
- YCBD N/A
- TTNP N/A
- Industry
- YCBD Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YCBD Health Care
- TTNP Health Care
- Exchange
- YCBD Nasdaq
- TTNP Nasdaq
- Market Cap
- YCBD 3.2M
- TTNP 3.4M
- IPO Year
- YCBD N/A
- TTNP 1996
- Fundamental
- Price
- YCBD $0.30
- TTNP $4.00
- Analyst Decision
- YCBD
- TTNP
- Analyst Count
- YCBD 0
- TTNP 0
- Target Price
- YCBD N/A
- TTNP N/A
- AVG Volume (30 Days)
- YCBD 965.3K
- TTNP 33.6K
- Earning Date
- YCBD 05-14-2025
- TTNP 05-14-2025
- Dividend Yield
- YCBD N/A
- TTNP N/A
- EPS Growth
- YCBD N/A
- TTNP N/A
- EPS
- YCBD N/A
- TTNP N/A
- Revenue
- YCBD $19,220,238.00
- TTNP N/A
- Revenue This Year
- YCBD $13.00
- TTNP N/A
- Revenue Next Year
- YCBD $10.00
- TTNP N/A
- P/E Ratio
- YCBD N/A
- TTNP N/A
- Revenue Growth
- YCBD N/A
- TTNP N/A
- 52 Week Low
- YCBD $0.21
- TTNP $3.03
- 52 Week High
- YCBD $1.25
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- YCBD 47.12
- TTNP 55.27
- Support Level
- YCBD $0.21
- TTNP $3.48
- Resistance Level
- YCBD $0.42
- TTNP $4.47
- Average True Range (ATR)
- YCBD 0.04
- TTNP 0.35
- MACD
- YCBD 0.01
- TTNP 0.01
- Stochastic Oscillator
- YCBD 44.43
- TTNP 56.07
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.